ArticleStem cell research & therapy2021

Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.

Linli Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.